Publications by authors named "Daniel Childs"

Claim this Profile
C
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis.
Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Kunwer Sufyan Faisal, Huan He, Kaneez Zahra Rubab Khakwani, Daniel S Childs

Eur Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Toxicities of PSMA-Targeted Therapies: Mitigation Strategies and Translational Opportunities.
Chitra Priya Emperumal, Nagarajan Kannan, Daniel S Childs, Bridget P Keenan

Clin Genitourin Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited DNA repair variants are associated with clonal hematopoiesis and cardiovascular risk in men with metastatic prostate cancer.
Olisaemeka Ogbue, Yael Kusne, Osama Mosalem, Kevin Thompson, Alejandro Ferrer, Daniel Childs

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium prostate-specific antigen membrane therapy.
Yael Kusne, Osama M Mosalem, Jaxon Quillen, Skye Buckner-Petty, Miguel Muniz, Daniel S Childs

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA Testing.
Miguel Muniz, L Jill Tsai, Jacob J Orme, Leslie A Bucheit, Spyridon P Basourakos, Daniel S Childs

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors.
Regina M Koch, Miguel Muniz, Candy S Peskey, Aminah Jatoi, Kathryn J Ruddy, Daniel S Childs

J Pain Symptom Manage· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysis.
Daniel S Roberson, Vidit Sharma, Stephen A Boorjian, Matthew T McLeay, Giuseppe Reitano, Daniel S Childs

Eur Urol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for [Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer.
Miguel Muniz, Oliver Sartor, Jacob J Orme, Regina M Koch, Zachary Scharf, Daniel S Childs

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases.
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, Matthew P Thorpe, Ann T Packard, Daniel S Childs

Eur J Nucl Med Mol Imaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients.
Surendra Dasari, Michael R McCarthy, Antonina A Wojcik, Beth A Pitel, Arpan Samaddar, Daniel S Childs

Prostate Cancer Prostatic Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis.
Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz, Arifa Bibi, Muhammad Ali Khan, Manal Imran, Daniel S Childs

Eur Urol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race and Outcomes to [Lu]Lu-PSMA-617 in Advanced Prostate Cancer.
Avina Rami, Caiwei Zhong, Miguel Muniz, Wanling Xie, Adam Khorasanchi, Daniel S Childs

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy.
Miguel Muniz, Daniel S Childs, Jack Andrews, Ahmed M Mahmoud, Sean Park

Ann Transl Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future directions in theranostics for neuroendocrine prostate cancer.
Gokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, Jacob J Orme, Daniel S Childs

Cancer Treat Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-field prostate cancer recurrence following radical prostatectomy and salvage radiation.
Austin Martin, Ahmed M Mahmoud, Cameron J Britton, Anthony Fadel, Mohamed E Ahmed, Daniel S Childs

BJU Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic treatment options for metastatic castration resistant prostate cancer: A living systematic review.
Syed Arsalan Ahmed Naqvi, Muhammad Umair Anjum, Arifa Bibi, Muhammad Ali Khan, Kaneez Zahra Rubab Khakwani, Daniel S Childs

medRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.
Jack R Andrews, Yohan Kim, Edlira Horjeti, Ali Arafa, Heather Gunn, Daniel S Childs

Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial.
Jacob J Orme, Henan Zhang, Prashanth Lingamaneni, Yohan Kim, Roxane Lavoie, Daniel S Childs

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [Lu]Lu-PSMA-617.
Miguel Muniz, Oliver Sartor, Jacob J Orme, Regina M Koch, Hana R Rosenow, Daniel S Childs

J Nucl Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic Symptoms After Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, Jacob J Orme, Daniel S Childs

J Nucl Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Patterns Based on First-site-specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?
Mohamed E Ahmed, Ahmed M Mahmoud, Guiseppe Reitano, Wael Zeina, Kelly Lehner, Daniel S Childs

Eur Urol Open Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer Lu-PSMA-617 therapy.
Gokce Belge Bilgin, Cem Bilgin, Daniel S Childs, Jacob J Orme, Brian J Burkett

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.
Miguel Muniz, Charles L Loprinzi, Jacob J Orme, Regina M Koch, Ahmed M Mahmoud, Daniel S Childs

Cancer Treat Rev· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies.
Ahmed M Mahmoud, Amr Moustafa, Carter Day, Mohamed E Ahmed, Wael Zeina, Daniel S Childs

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theranostics and artificial intelligence: new frontiers in personalized medicine.
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, Jacob J Orme, Daniel S Childs

Theranostics· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis